Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Shapiro

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|September 7, 2020
Causal Diagram Techniques for Urologic Oncology ResearchDaniel D Shapiro, Pavlos Msaouel
Urologic Oncology|July 13, 2024
Adjuvant therapy for renal cell carcinoma: Finding the signal in the noiseDaniel D Shapiro, Pavlos Msaouel
European Urology|October 29, 2024
Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to PowerDaniel D Shapiro, Pavlos Msaouel
Cancer|April 25, 2020
Renal cell carcinoma with isolated lymph node metastases should be reclassified as stage IVDaniel D Shapiro, E Jason Abel
Annals of Translational Medicine|February 12, 2019
Predicting aggressive behavior in small renal tumors prior to treatmentDaniel D Shapiro, E Jason Abel
The Journal of Urology|June 23, 2017
Editorial CommentDaniel D Shapiro, E Jason Abel
Urology|January 30, 2026
EDITORIAL COMMENT ON "OUTCOMES OF PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA ON IMMUNOSUPPRESSION FOLLOWING SOLID ORGAN TRANSPLANTATION"Parth V Shah, Daniel D Shapiro
Urology Practice|June 15, 2023
Editorial CommentaryDaniel D Shapiro, Justin R Gregg
Current Opinion in Urology|July 16, 2019
Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitorsDaniel D Shapiro, E Jason Abel
The Journal of Urology|August 9, 2022
Editorial CommentMary E Westerman, Daniel D Shapiro
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|September 7, 2020
Causal Diagram Techniques for Urologic Oncology ResearchDaniel D Shapiro, Pavlos Msaouel
Urologic Oncology|July 13, 2024
Adjuvant therapy for renal cell carcinoma: Finding the signal in the noiseDaniel D Shapiro, Pavlos Msaouel
European Urology|October 29, 2024
Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to PowerDaniel D Shapiro, Pavlos Msaouel
Cancer|April 25, 2020
Renal cell carcinoma with isolated lymph node metastases should be reclassified as stage IVDaniel D Shapiro, E Jason Abel
Annals of Translational Medicine|February 12, 2019
Predicting aggressive behavior in small renal tumors prior to treatmentDaniel D Shapiro, E Jason Abel
The Journal of Urology|June 23, 2017
Editorial CommentDaniel D Shapiro, E Jason Abel
Urology|January 30, 2026
EDITORIAL COMMENT ON "OUTCOMES OF PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA ON IMMUNOSUPPRESSION FOLLOWING SOLID ORGAN TRANSPLANTATION"Parth V Shah, Daniel D Shapiro
Urology Practice|June 15, 2023
Editorial CommentaryDaniel D Shapiro, Justin R Gregg
Current Opinion in Urology|July 16, 2019
Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitorsDaniel D Shapiro, E Jason Abel
The Journal of Urology|August 9, 2022
Editorial CommentMary E Westerman, Daniel D Shapiro
Pageof 7